Med24
metabolic-therapy 30. 10. 2026 • 2 min read • Biology of reproduction (PubMed)

Effects of Polyendocrine Metabolic Ovarian Syndrome (PMOS) on the Endometrium.

Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is the most common reproductive, endocrine, and metabolic disorder affecting 11-13% of adolescent girls and women of reproductive age. Although anovulation has traditionally been considered the primary cause of...

Anemia ja kuolevuus ikääntyvillä – PolSenior-tutkimuksen kuva.

Polyendocrine metabolic ovarian syndrome (PMOS), affecting approximately 11-13% of adolescent girls and women of reproductive age, is characterized by anovulation. Evidence indicates that impaired endometrial receptivity and decidualization significantly contribute to infertility, recurrent pregnancy loss, and adverse pregnancy outcomes such as miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and preterm birth. Women with PMOS frequently experience obesity, insulin resistance, and chronic inflammation.

Mechanisms of PMOS

Research explores the cellular and molecular mechanisms by which PMOS disrupts endometrial function. Hyperandrogenism, insulin resistance, obesity, and chronic inflammation collectively impair endometrial receptivity through alterations in androgen receptor signaling, glucose metabolism, extracellular matrix remodeling, immune homeostasis, cell-cell junctions, adhesion molecules, and key regulators of decidualization. Transcriptomic and single-cell sequencing studies have revealed cell type-specific alterations and molecular heterogeneity within the PMOS endometrium.

Sponsored content

Goals of Research

These investigations aim to improve embryo implantation success, pregnancy outcomes, and reproductive health in women with PMOS. Further understanding of the connections between endocrine and metabolic abnormalities and endometrial dysfunction is needed.

Original Scientific Source
Biology of reproduction (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement